{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:55:49Z","timestamp":1792007749213,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870404"],"award-info":[{"award-number":["81870404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100648"],"award-info":[{"award-number":["82100648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajcnut.2023.02.008","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T10:37:17Z","timestamp":1676111837000},"page":"691-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: A randomized controlled trial"],"prefix":"10.1016","volume":"117","author":[{"given":"Xiongcai","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congxiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4638-7699","authenticated-orcid":false,"given":"Bihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajcnut.2023.02.008_bib1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/liv.15188","article-title":"The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint","volume":"42","author":"Farahat","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib2","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.934134","article-title":"A\u00a0review of the increasing prevalence of metabolic-associated fatty liver disease (MAFLD) in children and adolescents worldwide and in Mexico and the implications for public health","volume":"27","author":"Ram\u00edrez-Mej\u00eda","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib4","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40200-019-00475-2","article-title":"Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations","volume":"19","author":"Akhlaghi","year":"2020","journal-title":"J.\u00a0Diabetes Metab. Disord."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-01223-3","article-title":"The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib9","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3390\/nu11122985","article-title":"High protein diet and metabolic plasticity in non-alcoholic fatty liver disease: myths and truths","volume":"11","author":"De Chiara","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/met.2019.0038","article-title":"The effect of low glycemic index and glycemic load diets on hepatic Fat Mass, insulin resistance, and blood lipid panels in individuals with nonalcoholic fatty liver disease","volume":"17","author":"Parker","year":"2019","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium prausnitzii and human intestinal health","volume":"16","author":"Miquel","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200831010-00005","article-title":"Orlistat-associated adverse effects and drug interactions: a critical review","volume":"31","author":"Filippatos","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib13","first-page":"90","article-title":"Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"9","author":"Wang","year":"2018","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211033119","article-title":"Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease","volume":"12","author":"Shao","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13446","article-title":"A\u00a0meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease","volume":"51","author":"Gu","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib17","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1136\/gutjnl-2020-323106","article-title":"Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial","volume":"70","author":"Yaskolka Meir","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fendo.2020.00070","article-title":"Effect of weight loss medications on hepatic steatosis and steatohepatitis: a systematic review","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819879047","article-title":"Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction","volume":"12","author":"Ye","year":"2019","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajg.2020.12.005","article-title":"Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome","volume":"22","author":"Esmail","year":"2021","journal-title":"Arab. J. Gastroenterol."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ehjcvp\/pvaa133","article-title":"Long-term cardiovascular outcomes after orlistat therapy in patients with obesity: a nationwide, propensity-score matched cohort study","volume":"8","author":"Ardissino","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12020-014-0426-4","article-title":"Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial","volume":"49","author":"Moini","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12325-018-0835-5","article-title":"Efficacy and safety of lipase inhibitor orlistat in Japanese with excessive visceral fat accumulation: 24-week, double-blind, randomized, placebo-controlled study","volume":"36","author":"Shirai","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155136","article-title":"The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials","volume":"129","author":"Angelidi","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clnu.2019.11.026","article-title":"Low-carbohydrate diets and intrahepatic lipid content in individuals with non-alcoholic fatty liver disease: evidence from a meta-analysis of randomized trials","volume":"39","author":"Bueno","year":"2020","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/nu14010049","article-title":"Association between non-alcoholic fatty liver disease and Mediterranean lifestyle: a systematic review","volume":"14","author":"Mascar\u00f3","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib29","first-page":"155","article-title":"Consumption of a high-protein meal replacement leads to higher fat oxidation, suppression of hunger, and improved metabolic profile after an exercise session","volume":"13","author":"Oliveira","year":"2021","journal-title":"J.\u00a0Nutrients"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/obr.12816","article-title":"A\u00a0systematic review and meta-analysis of the effectiveness of meal replacements for weight loss","volume":"20","author":"Astbury","year":"2019","journal-title":"Obes. Rev."},{"key":"10.1016\/j.ajcnut.2023.02.008_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/nu13020376","article-title":"Effects of a protein-rich, low-glycaemic meal replacement on changes in dietary intake and body weight following a weight-management intervention-the ACOORH trial","volume":"13","author":"R\u00f6hling","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ajcnut.2023.02.008_bib32","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/nu13051433","article-title":"High-protein, low-glycaemic meal replacement decreases fasting insulin and inflammation markers-A 12-month subanalysis of the ACOORH trial","volume":"13","author":"Kempf","year":"2021","journal-title":"Nutrients"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523041540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523041540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:56:01Z","timestamp":1757573761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523041540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0002916523041540"],"URL":"https:\/\/doi.org\/10.1016\/j.ajcnut.2023.02.008","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajcnut.2023.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}]}}